Collectively, these findings underscore the potential gene-specific heterogeneity of ABC transporter biology in schizophrenia: ABCC1 may relate to inflammatory variability, ABCB1 may reflect pharmacodynamic differences, and ABCA2 may index treatment-associated metabolic adaptations. Here, ABCG2 is linked to schizophrenia.